JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 45 filers reported holding JANUX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,614,811 | +36.7% | 3,434,009 | +60.9% | 0.01% | +40.0% |
| Q2 2023 | $25,329,085 | +9.8% | 2,133,874 | +11.9% | 0.01% | 0.0% |
| Q1 2023 | $23,077,435 | -8.6% | 1,907,226 | -0.5% | 0.01% | -16.7% |
| Q4 2022 | $25,239,132 | +0.6% | 1,916,411 | +3.4% | 0.01% | 0.0% |
| Q3 2022 | $25,093,000 | +10.9% | 1,853,216 | -0.0% | 0.01% | 0.0% |
| Q2 2022 | $22,630,000 | -14.9% | 1,853,432 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $26,578,000 | -27.3% | 1,853,432 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $36,568,000 | -7.8% | 1,853,432 | -0.3% | 0.01% | -12.5% |
| Q3 2021 | $39,642,000 | -14.3% | 1,859,246 | -1.5% | 0.01% | -20.0% |
| Q2 2021 | $46,239,000 | – | 1,886,712 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |